Reference
Sheikh-Taha M. Idarucizumab for Reversal of Dabigatran: Single-Center Real-World Experience. American Journal of Cardiovascular Drugs : [6 pages], 11 Sep 2018. Available from: URL: http://dx.doi.org/10.1007/s40256-018-0300-5
Rights and permissions
About this article
Cite this article
Idarucizumab reverses haemorrhagic effects of dabigatran. Reactions Weekly 1721, 7 (2018). https://doi.org/10.1007/s40278-018-52044-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-52044-2